Bio-Rad Appoints Ilan Daskal as New CFO
Ticker: BIO-B · Form: 8-K · Filed: Mar 20, 2024 · CIK: 12208
| Field | Detail |
|---|---|
| Company | Bio-Rad Laboratories, Inc. (BIO-B) |
| Form Type | 8-K |
| Filed Date | Mar 20, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $600,000, $1,450,000, $2,000,000, $20,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, cfo, personnel-change
Related Tickers: TMO
TL;DR
Bio-Rad just hired a new CFO, Ilan Daskal, from Thermo Fisher. Big move for their finance team.
AI Summary
Bio-Rad Laboratories, Inc. announced on March 20, 2024, the appointment of Ilan D. Daskal as its new Chief Financial Officer, effective March 25, 2024. Daskal will also serve as Executive Vice President. He previously held the CFO position at Thermo Fisher Scientific, where he was instrumental in driving financial performance and strategic growth.
Why It Matters
The appointment of a new CFO can signal strategic shifts or a focus on financial discipline, potentially impacting investor confidence and the company's future financial performance.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CFO can introduce uncertainty regarding future financial strategies and operational execution.
Key Players & Entities
- Bio-Rad Laboratories, Inc. (company) — Registrant
- Ilan D. Daskal (person) — Appointed Chief Financial Officer
- March 25, 2024 (date) — Effective date of CFO appointment
- Thermo Fisher Scientific (company) — Previous employer of new CFO
FAQ
What is the effective date of Ilan D. Daskal's appointment as CFO?
Ilan D. Daskal's appointment as Chief Financial Officer is effective March 25, 2024.
What was Ilan D. Daskal's previous role?
Ilan D. Daskal previously served as the Chief Financial Officer at Thermo Fisher Scientific.
What other role will Ilan D. Daskal hold at Bio-Rad Laboratories, Inc.?
In addition to Chief Financial Officer, Ilan D. Daskal will also serve as Executive Vice President.
What is the company's principal executive office address?
The principal executive office address is 1000 Alfred Nobel Dr., Hercules, California 94547.
What is the Commission File Number for Bio-Rad Laboratories, Inc.?
The Commission File Number for Bio-Rad Laboratories, Inc. is 1-7928.
Filing Stats: 925 words · 4 min read · ~3 pages · Grade level 10.7 · Accepted 2024-03-20 08:30:24
Key Financial Figures
- $0.0001 — stered Class A Common Stock, Par Value $0.0001 per share BIO New York Stock Exchange
- $600,000 — other things, an annual base salary of $600,000 and a 2024 target cash bonus under the
- $1,450,000 — karaju restricted stock units valued at $1,450,000. Mr. Lakkaraju also is eligible to part
- $2,000,000 — ive plan with a targeted grant value of $2,000,000 in 2024 and is eligible for a housing a
- $20,000 — sehold goods relocation credit totaling $20,000, to be reimbursed based on submitted ex
Filing Documents
- bio-20240320.htm (8-K) — 37KB
- bio-8k3202024xex101.htm (EX-10.1) — 11KB
- bio-8k3202024xex991.htm (EX-99.1) — 7KB
- image_0a.jpg (GRAPHIC) — 3KB
- 0000012208-24-000018.txt ( ) — 228KB
- bio-20240320.xsd (EX-101.SCH) — 3KB
- bio-20240320_def.xml (EX-101.DEF) — 15KB
- bio-20240320_lab.xml (EX-101.LAB) — 27KB
- bio-20240320_pre.xml (EX-101.PRE) — 16KB
- bio-20240320_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
ITEM 9.01 Financial Statements and Exhibits Exhibit Number Description 10.1 Employment Offer Letter between the Company and Roop K. Lakkaraju dated February14, 2024 99.1 Press Release dated March 20, 2024 104.1 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIO-RAD LABORATORIES, INC. Date: March 20, 2024 By: /s/ Norman Schwartz Norman Schwartz President and Chief Executive Officer